To the full analysis
Universal Health Realty Income Trust stock: growth
UHTUniversal Health Realty Income Trust reported $99.19M in revenue for fiscal 2025, up 0.2% on the prior year, up 4.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
6.2%
per year from 2006 to 2025, per share 5.3%
Earnings (Annual rate)
−3.5%
per year from 2006 to 2025, per share −4.3%
Free cash flow (Annual rate)
4%
per year from 2006 to 2025, per share 3.1%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 4.9% | 4.5% | 6.2% |
| Revenue per share | 4.8% | 4.1% | 5.3% |
| Earnings | −2.0% | −2.9% | −3.5% |
| Earnings per share | −2.2% | −3.3% | −4.3% |
| Free cash flow | 3.2% | 8.7% | 4.0% |
| Free cash flow per share | 3.1% | 8.2% | 3.1% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $31.71M | $34.7M | $23.41M |
| 2007 | $27.96M | $22.19M | $15.54M |
| 2008 | $29.18M | $11.65M | $17.13M |
| 2009 | $31.91M | $18.58M | $37.35M |
| 2010 | $28.88M | $16.31M | $22.08M |
| 2011 | $29.49M | $73.79M | −$18.98M |
| 2012 | $53.95M | $19.48M | $13.18M |
| 2013 | $54.28M | $13.17M | $26.62M |
| 2014 | $59.79M | $51.55M | $17.2M |
| 2015 | $63.95M | $23.69M | $21.41M |
| 2016 | $67.08M | $17.22M | −$19.66M |
| 2017 | $72.35M | $45.62M | $36.97M |
| 2018 | $76.21M | $24.2M | $38.88M |
| 2019 | $77.16M | $18.96M | $37.55M |
| 2020 | $78.01M | $19.45M | $41.94M |
| 2021 | $84.19M | $109.17M | $34.74M |
| 2022 | $90.63M | $21.1M | $33.19M |
| 2023 | $95.58M | $15.4M | $43.47M |
| 2024 | $99.01M | $19.23M | $46.91M |
| 2025 | $99.19M | $17.61M | $49.09M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 17 Jan 2025)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.